Studies have confirmed the often large Studies have confirmed the often large differences that exist between the conditions differences that exist between the conditions of pre-marketing trials and those of actual of pre-marketing trials and those of actual practice several years into the market life practice several years into the market life of a pharmaceutical product (Martin of a pharmaceutical product (Martin et al et al, , 2004 (Martin et al et al, , 2004a . A clinical trial is necessarily based ). A clinical trial is necessarily based on a small sample of people selected from on a small sample of people selected from the source population by inclusion and the source population by inclusion and non-inclusion criteria in order to reduce non-inclusion criteria in order to reduce inter-individual variability. These people inter-individual variability. These people are usually treated with a fixed protocol, are usually treated with a fixed protocol, specifying dosage, duration and conspecifying dosage, duration and concomitant medications. Pre-marketing data comitant medications. Pre-marketing data must therefore be complemented by a field must therefore be complemented by a field assessment to measure any eventual distorassessment to measure any eventual distortions and to estimate their consequences on tions and to estimate their consequences on real-life effectiveness and safety. Pharmacoreal-life effectiveness and safety. Pharmacoepidemiology is an interface discipline that epidemiology is an interface discipline that can be defined as the study of the intercan be defined as the study of the interactions between drugs and populations actions between drugs and populations (Begaud, 2000) . Its objective is to assess (Bégaud, 2000) . Its objective is to assess the utilisation and impact (benefit and risk the utilisation and impact (benefit and risk in 'real life' conditions) of health care in 'real life' conditions) of health care products at the level of the population actuproducts at the level of the population actually treated, not just on the theoretical ally treated, not just on the theoretical target population as defined by pretarget population as defined by premarketing trials and marketing authorisamarketing trials and marketing authorisation. Although tion. Although they follow the three classithey follow the three classical areas of epidemiology (cross-sectional, cal areas of epidemiology (cross-sectional, prospective or retrospective studies), prospective or retrospective studies), pharmaco-epidemiological studies have to pharmaco-epidemiological studies have to handle the specific problems associated handle the specific problems associated with drugs, such as multiform and unprewith drugs, such as multiform and unpredictable risk, sometimes very low incidence dictable risk, sometimes very low incidence rates, dynamics and variability of exposure, rates, dynamics and variability of exposure, and large number of drugs available on the and large number of drugs available on the market. This has justified the development market. This has justified the development of adapted pharmaco-epidemiological of adapted pharmaco-epidemiological approaches, such as spontaneous reporting, approaches, such as spontaneous reporting, case-population studies, case-crossover case-population studies, case-crossover and case-time designs. The pharmacoand case-time designs. The pharmacoepidemiological approach has already been epidemiological approach has already been fruitfully applied to the investigation of fruitfully applied to the investigation of the prescription of psychotropic medicathe prescription of psychotropic medications at the population level; however, tions at the population level; however, this field of research needs to be further this field of research needs to be further developed owing to the large number of developed owing to the large number of medical, ethical medical, ethical and economic questions and economic questions raised by the extensive and expanding use raised by the extensive and expanding use of psychotropic drugs. of psychotropic drugs. (Barbui et al et al, 2002) . Using the , 2002) . Using the French social security insurance database, French social security insurance database, we found that the prescription pattern of we found that the prescription pattern of risperidone was characterised by a high risperidone was characterised by a high level of concomitant drug prescription level of concomitant drug prescription (Martin (Martin et al et al, 2004 (Martin et al et al, , 2004b . In particular, anti-). In particular, antidepressants were co-prescribed in 43% of depressants were co-prescribed in 43% of patients treated with risperidone, although patients treated with risperidone, although the efficacy and safety of such cothe efficacy and safety of such coprescription has been insufficiently investiprescription has been insufficiently investigated in clinical trials. An anticholinergic gated in clinical trials. An anticholinergic drug was co-prescribed in 19% of the drug was co-prescribed in 19% of the people studied (16% of those treated with people studied (16% of those treated with a dosage of less than 6 mg), suggesting that a dosage of less than 6 mg), suggesting that the marketing claim of a low incidence of the marketing claim of a low incidence of extrapyramidal side-effects with risperiextrapyramidal side-effects with risperidone prescribed at recommended dosage done prescribed at recommended dosage might not be confirmed in naturalistic might not be confirmed in naturalistic conditions. conditions.
UTILISATION STUDIES UTILISATION STUDIES
Utilisation studies are also fundamental Utilisation studies are also fundamental to identifying possibly unfounded or hazarto identifying possibly unfounded or hazardous extensions of the indications for psydous extensions of the indications for psychotropic medications. The widening of chotropic medications. The widening of the boundaries of treatable illness, often the boundaries of treatable illness, often favoured by the marketing pressure favoured by the marketing pressure of pharof pharmaceutical companies, is not specific maceutical companies, is not specific to psyto psychiatry (Moynihan chiatry (Moynihan et al et al, 2002) , but it is a , 2002), but it is a phenomenon to which the specialty is partiphenomenon to which the specialty is particularly vulnerable; uncertainty regarding cularly vulnerable; uncertainty regarding the boundaries between normality and the boundaries between normality and caseness allows the creation of new diagcaseness allows the creation of new diagnostic categories of putatively treatable nostic categories of putatively treatable psychiatric disorders. An example of a psychiatric disorders. An example of a potentially hazardous extension of indication potentially hazardous extension of indication can be drawn from community surveys can be drawn from community surveys showing that a large percentage of children showing that a large percentage of children and adolescents treated with psychoand adolescents treated with psychostimulant drugs do not fulfil the diagnostic stimulant drugs do not fulfil the diagnostic criteria for attention-deficit hyperactivity criteria for attention-deficit hyperactivity disorder (Rey & Sawyer, 2003) . Early disorder (Rey & Sawyer, 2003) . Early intervention in psychosis provides an illusintervention in psychosis provides an illustration of extension of indication generated tration of extension of indication generated by the creation of a new diagnostic cateby the creation of a new diagnostic category with need of care. Owing to the lack gory with need of care. Owing to the lack of valid screening tests, it is not yet clearly of valid screening tests, it is not yet clearly established at the population level whether established at the population level whether the benefits of antipsychotic medication in the benefits of antipsychotic medication in people with preclinical psychosis are superpeople with preclinical psychosis are superior to the risks linked to unjustified ior to the risks linked to unjustified prescription in cases with a false-positive prescription in cases with a false-positive diagnosis (Verdoux & Cougnard, 2003) . diagnosis (Verdoux & Cougnard, 2003) . However, it is striking that interest in early However, it is striking that interest in early intervention markedly increased when new intervention markedly increased when new antipsychotic drugs became available, and antipsychotic drugs became available, and the enthusiastic support of early interthe enthusiastic support of early intervention programmes by pharmaceutical vention programmes by pharmaceutical companies suggests that they at least have companies suggests that they at least have little doubt about the benefits they can little doubt about the benefits they can obtain from this strategy. The current obtain from this strategy. The current promotion of the use of antipsychotics not promotion of the use of antipsychotics not only in preclinical psychosis but also in only in preclinical psychosis but also in bipolar disorder and behavioural disturbipolar disorder and behavioural disturbances of dementia may reassure prescribances of dementia may reassure prescribers about the safety of these drugs, bers about the safety of these drugs, inducing their even more widespread use. inducing their even more widespread use. It is thus necessary to explore at the popuIt is thus necessary to explore at the population level whether the utilisation pattern lation level whether the utilisation pattern of these drugs is altered, not only in psychiof these drugs is altered, not only in psychiatric settings, but also in primary care. Sevatric settings, but also in primary care. Several other examples could be given for each eral other examples could be given for each class of psychotropic medication, pointing class of psychotropic medication, pointing to the need for studies examining utilisation to the need for studies examining utilisation patterns in naturalistic conditions in order patterns in naturalistic conditions in order to identify discrepancies between guidelines to identify discrepancies between guidelines based on clinical trials and actual use. based on clinical trials and actual use.
OUTCOME STUDIES OUTCOME STUDIES
Although clinical trials may identify the Although clinical trials may identify the most frequent adverse effects associated most frequent adverse effects associated with the use of psychotropic medications, with the use of psychotropic medications, they are of limited value in detecting they are of limited value in detecting delayed or less prevalent risks linked to delayed or less prevalent risks linked to exposure to a new drug. Such adverse reacexposure to a new drug. Such adverse reactions have to be identified as early as posstions have to be identified as early as possible, since even a small increase in risk may ible, since even a small increase in risk may 9 3 9 3 2002) . , 2002). Another major issue addressed by outAnother major issue addressed by outcome studies is the risk of psychiatric come studies is the risk of psychiatric disorders induced by prescription of disorders induced by prescription of psychotropic or non-psychotropic drugs. A psychotropic or non-psychotropic drugs. A further example of the usefulness of further example of the usefulness of population-based studies is provided by population-based studies is provided by the debate on the suspected link between the debate on the suspected link between autism and exposure to the measles, mumps autism and exposure to the measles, mumps and rubella triple vaccination. Findings and rubella triple vaccination. Findings obtained in clinical samples of uncertain obtained in clinical samples of uncertain representativity generated a huge scientific representativity generated a huge scientific controversy, widely amplified by the media. controversy, widely amplified by the media. There is now strong evidence against this There is now strong evidence against this hypothesis, as rigorous population-based hypothesis, as rigorous population-based studies have failed to find such an associastudies have failed to find such an association (DeStefano & Thompson, 2002; tion (DeStefano & Thompson, 2002; Madsen Madsen et al et al, 2002) . A markedly under-, 2002) . A markedly underdeveloped field of investigation concerns developed field of investigation concerns the delayed psychiatric risks associated the delayed psychiatric risks associated with psychotropic use; for example, the with psychotropic use; for example, the possible risk of dementia associated with possible risk of dementia associated with exposure to benzodiazepines needs to be exposure to benzodiazepines needs to be further explored owing to the public health further explored owing to the public health consequences of such a finding (Lagnaoui consequences of such a finding (Lagnaoui et et al al, 2002) . , 2002). Another major public health issue Another major public health issue concerns the psychiatric consequences of concerns the psychiatric consequences of medication prescription during pregnancy. medication prescription during pregnancy. Although the association between exposure Although the association between exposure to perinatal risk factors and increased to perinatal risk factors and increased vulnerability for psychiatric disorder is well vulnerability for psychiatric disorder is well documented, knowledge is strikingly sparse documented, knowledge is strikingly sparse regarding the impact of prenatal exposure regarding the impact of prenatal exposure to prescribed drugs on the delayed risk of to prescribed drugs on the delayed risk of psychiatric disorder (Verdoux, 2002) . psychiatric disorder (Verdoux, 2002) .
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
Owing to their methodological limitations, Owing to their methodological limitations, no definite conclusion regarding behavioural no definite conclusion regarding behavioural teratogenicity can be drawn from most teratogenicity can be drawn from most studies exploring the risk associated with studies exploring the risk associated with prenatal exposure to psychotropic mediprenatal exposure to psychotropic medication (Walker cation (Walker et al et al, 1999) . Sparse findings , 1999). Sparse findings suggest that exposure to xenoestrogens suggest that exposure to xenoestrogens such as diethylstilbestrol may be a risk such as diethylstilbestrol may be a risk factor for psychiatric disorders, mediated factor for psychiatric disorders, mediated by a possible deleterious impact of these by a possible deleterious impact of these substances on foetal neurodevelopment, substances on foetal neurodevelopment, but this hypothesis is speculative owing to but this hypothesis is speculative owing to the small number of studies and their the small number of studies and their methodological limitations (Verdoux, methodological limitations (Verdoux, 2002) . The most convincing pharmaco -2002) . The most convincing pharmacoepidemiological study to date is one using epidemiological study to date is one using data on drug exposure prospectively data on drug exposure prospectively collected on 7866 persons in the Copenhagen collected on 7866 persons in the Copenhagen Perinatal Cohort (1959 Cohort ( -1961 , cases of Perinatal Cohort (1959 Cohort ( -1961 , cases of schizophrenia being identified through the schizophrenia being identified through the Danish Psychiatric Central Register (Sorensen Danish Psychiatric Central Register (Sorensen et al et al, 2003) .
, 2003). After adjustment for confoundAfter adjustment for confounding factors, risk of schizophrenia was found ing factors, risk of schizophrenia was found to be increased in people exposed to materto be increased in people exposed to maternal diuretic treatment during the third trinal diuretic treatment during the third trimester of pregnancy and was especially mester of pregnancy and was especially marked in individuals also exposed to marked in individuals also exposed to maternal hypertension. maternal hypertension.
CONCLUSION CONCLUSION
More and more people are exposed to preMore and more people are exposed to prescribed psychotropic drugs at all stages of scribed psychotropic drugs at all stages of the life cycle, from prenatal life to old the life cycle, from prenatal life to old age. Beyond the societal questions raised age. Beyond the societal questions raised by this medical practice, the utilisation by this medical practice, the utilisation and impact of psychotropic drugs have to and impact of psychotropic drugs have to be further explored at the population level. be further explored at the population level. Pharmaco-epidemiological research conPharmaco-epidemiological research conducted independently of drug companies is ducted independently of drug companies is therefore required to explore crucial public therefore required to explore crucial public health issues related to psychotropic drug health issues related to psychotropic drug use, such as the medical and economic use, such as the medical and economic impact of unjustified extension of use, the impact of unjustified extension of use, the identification of infrequent or delayed identification of infrequent or delayed adverse effects, and the efficiency of new adverse effects, and the efficiency of new marketed products in naturalistic conditions. marketed products in naturalistic conditions. 
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